Moderna tumbles 19% on reduced 2025 revenue outlook

Moderna Inc.’s shares plummeted by more than 19% on Monday after the company updated its financial projections for fiscal 2025 and announced it anticipates a revenue of between $1.5 billion and $2.5 b…